6-52438493-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_018100.4(EFHC1):c.475C>T(p.Arg159Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.112 in 1,613,778 control chromosomes in the GnomAD database, including 11,090 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R159G) has been classified as Likely benign.
Frequency
Consequence
NM_018100.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EFHC1 | NM_018100.4 | c.475C>T | p.Arg159Trp | missense_variant | 3/11 | ENST00000371068.11 | |
EFHC1 | NM_001172420.2 | c.418C>T | p.Arg140Trp | missense_variant | 4/12 | ||
EFHC1 | NR_033327.2 | n.544C>T | non_coding_transcript_exon_variant | 3/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EFHC1 | ENST00000371068.11 | c.475C>T | p.Arg159Trp | missense_variant | 3/11 | 1 | NM_018100.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0979 AC: 14878AN: 152016Hom.: 823 Cov.: 32
GnomAD3 exomes AF: 0.102 AC: 25501AN: 251084Hom.: 1491 AF XY: 0.104 AC XY: 14064AN XY: 135724
GnomAD4 exome AF: 0.114 AC: 166554AN: 1461644Hom.: 10269 Cov.: 33 AF XY: 0.114 AC XY: 82864AN XY: 727132
GnomAD4 genome AF: 0.0978 AC: 14882AN: 152134Hom.: 821 Cov.: 32 AF XY: 0.0984 AC XY: 7321AN XY: 74368
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Juvenile myoclonic epilepsy Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 04, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Absence seizure;C1850778:Myoclonic epilepsy, juvenile, susceptibility to, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at